Table 2.
Individual subset predictive value: ROC analysis and cut-off for patients’ stratification as high-risk of progression.
| Normalised Naive | Normalised Treg | IRC | Risk-Score | ||
|---|---|---|---|---|---|
| At-risk participants n = 158 | AUC (range) | 0.313 (0.212–0.413) | 0.330 (0.227–0.432) | 0.313 (0.212–0.413) | 3 subsets |
| P | 0.001 | 0.003 | 0.001 | 02-Mar | |
| Cut-off | −10% | −3% | 4% | 93% | |
| Specificity | 80% | 82% | 80% | 36.50% | |
| Sensitivity | 41% | 35% | 41% | 4.95 | |
| OR | 1.95 | 2.3 | 1.95 | 74% | |
| PPV | 61% | 64% | 61% | 71.50% | |
| NPV | 63% | 63% | 63% | ||
| Evolving IA n = 294 | AUC (range) | 0.363 (0.281–0.446) 0.001 | 0.389 (0.307–0.471) | NA | 2 subsets |
| P | −10% | 0.01 | Absent/Present | ||
| Cut-off | 92% | −3% | 80% | ||
| Specificity | 51% | 83% | 69% | ||
| Sensitivity | 6.4 | 21% | 3.38 | ||
| OR | 84% | 1.5 | 83% | ||
| PPV | 69% | 80% | 64% | ||
| NPV | 29.5 | ||||
| MTX-induced Remission n = 120 | AUC (range) | 0.822 (0.710–0.933) | NA | NA | Naive subset only |
| P | <0.0001 | ||||
| Cut-off | 2.50% | ||||
| Specificity | 81% | ||||
| Sensitivity | 78% | ||||
| OR | 15.4 | ||||
| PPV | 78% | ||||
| NPV | 81% | ||||
| Remission/ Flare n = 145 | AUC (range) | 0.271 (0.151–0.389) <0.0001 | NA | NA | Naive subset only |
| P | −2.50% | ||||
| Cut-off | 77% | ||||
| Specificity | 62% | ||||
| Sensitivity | 2.7 | ||||
| OR | 43% | ||||
| PPV | 88% | ||||
| NPV | |||||
AUC: area under the curve (95% CI), OR: odd ratio, PPV: positive predictive value, NPV: negative predictive value, NA not applicable.